| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected and Quantified |
|---|
| Creation Date | 2006-08-13 19:18:32 UTC |
|---|
| Update Date | 2023-02-21 17:17:02 UTC |
|---|
| HMDB ID | HMDB0004461 |
|---|
| Secondary Accession Numbers | |
|---|
| Metabolite Identification |
|---|
| Common Name | Benzamide |
|---|
| Description | Benzamide, also known as PHC(=o)NH2 or phenylcarboxamide, belongs to the class of organic compounds known as benzamides. These are organic compounds containing a carboxamido substituent attached to a benzene ring. Benzamide exists in all living organisms, ranging from bacteria to humans. Benzamide is a bitter tasting compound. Benzamide has been detected, but not quantified in, a few different foods, such as anatidaes (Anatidae), chickens (Gallus gallus), and domestic pigs (Sus scrofa domestica). This could make benzamide a potential biomarker for the consumption of these foods. Benzamide is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. Based on a literature review a significant number of articles have been published on Benzamide. |
|---|
| Structure | InChI=1S/C7H7NO/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H2,8,9) |
|---|
| Synonyms | | Value | Source |
|---|
| Benzenecarboxamide | ChEBI | | Benzoic acid amide | ChEBI | | Benzoylamide | ChEBI | | PHC(=O)NH2 | ChEBI | | PHC(O)NH2 | ChEBI | | Phenylcarboxamide | ChEBI | | Phenylcarboxyamide | ChEBI | | Benzoate amide | Generator | | Amid kyseliny benzoove | HMDB | | Benzamide (acd/name 4.0) | HMDB | | Benzoate | HMDB | | Benzoic acid | HMDB | | Phenyl carboxyamide | HMDB | | Tigan | HMDB | | Trimethobenzamide hydrochloride | HMDB |
|
|---|
| Chemical Formula | C7H7NO |
|---|
| Average Molecular Weight | 121.1366 |
|---|
| Monoisotopic Molecular Weight | 121.052763851 |
|---|
| IUPAC Name | benzamide |
|---|
| Traditional Name | benzamide |
|---|
| CAS Registry Number | 55-21-0 |
|---|
| SMILES | NC(=O)C1=CC=CC=C1 |
|---|
| InChI Identifier | InChI=1S/C7H7NO/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H2,8,9) |
|---|
| InChI Key | KXDAEFPNCMNJSK-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as benzamides. These are organic compounds containing a carboxamido substituent attached to a benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Benzenoids |
|---|
| Class | Benzene and substituted derivatives |
|---|
| Sub Class | Benzoic acids and derivatives |
|---|
| Direct Parent | Benzamides |
|---|
| Alternative Parents | |
|---|
| Substituents | - Benzamide
- Benzoyl
- Primary carboxylic acid amide
- Carboxamide group
- Carboxylic acid derivative
- Organic nitrogen compound
- Organic oxygen compound
- Organopnictogen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Organonitrogen compound
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | |
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. Predicted by Afia on May 17, 2022. | 2.62 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 9.9661 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.58 minutes | 32390414 | | AjsUoB = Accucore 150 Amide HILIC with 10mM Ammonium Formate, 0.1% Formic Acid | 112.8 seconds | 40023050 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1129.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 358.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 108.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 219.6 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 79.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 274.4 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 323.1 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 265.3 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 756.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 269.6 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 875.8 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 217.2 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 265.5 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 436.8 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 282.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 140.3 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| Benzamide,1TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=CC=CC=C1 | 1406.7 | Semi standard non polar | 33892256 | | Benzamide,1TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=CC=CC=C1 | 1441.8 | Standard non polar | 33892256 | | Benzamide,1TMS,isomer #1 | C[Si](C)(C)NC(=O)C1=CC=CC=C1 | 1665.3 | Standard polar | 33892256 | | Benzamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC=CC=C1)[Si](C)(C)C | 1483.9 | Semi standard non polar | 33892256 | | Benzamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC=CC=C1)[Si](C)(C)C | 1522.4 | Standard non polar | 33892256 | | Benzamide,2TMS,isomer #1 | C[Si](C)(C)N(C(=O)C1=CC=CC=C1)[Si](C)(C)C | 1652.6 | Standard polar | 33892256 | | Benzamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=CC=CC=C1 | 1637.0 | Semi standard non polar | 33892256 | | Benzamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=CC=CC=C1 | 1608.4 | Standard non polar | 33892256 | | Benzamide,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NC(=O)C1=CC=CC=C1 | 1834.9 | Standard polar | 33892256 | | Benzamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 1910.4 | Semi standard non polar | 33892256 | | Benzamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 1918.1 | Standard non polar | 33892256 | | Benzamide,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(C(=O)C1=CC=CC=C1)[Si](C)(C)C(C)(C)C | 1902.7 | Standard polar | 33892256 |
|
|---|
| General References | - Chemnitius JM, Haselmeyer KH, Gonska BD, Kreuzer H, Zech R: Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood. Pharmacol Res. 1996 Jul-Aug;34(1-2):65-72. [PubMed:8981558 ]
- Coyle JD, MacKichan JJ, Boudoulas H, Lima JJ: Reversed-phase liquid chromatography method for measurement of procainamide and three metabolites in serum and urine: percent of dose excreted as deethyl metabolites. J Pharm Sci. 1987 May;76(5):402-5. [PubMed:2443639 ]
- Chiba R, Ogasawara A, Kubo T, Yamazaki H, Umino M, Ishizuka Y: Direct determination of benzamides in serum by column-switching high-performance liquid chromatography. Anal Sci. 2003 May;19(5):785-9. [PubMed:12769385 ]
- Yamamoto T, Hanioka N, Maeda Y, Imazumi K, Hamada K, Matsuo M, Manda T, Mutoh S: Contribution of tachykinin receptor subtypes to micturition reflex in guinea pigs. Eur J Pharmacol. 2003 Sep 23;477(3):253-9. [PubMed:14522364 ]
- Gschwend MH, Arnold P, Ring J, Martin W: Selective and sensitive determination of amisulpride in human plasma by liquid chromatography-tandem mass spectrometry with positive electrospray ionisation and multiple reaction monitoring. J Chromatogr B Analyt Technol Biomed Life Sci. 2006 Feb 2;831(1-2):132-9. Epub 2005 Dec 28. [PubMed:16386474 ]
- de Jong AP, Wittebrood AJ, du Chatinier WM, Bron J: Liquid chromatographic analysis of alizapride and metoclopramide in human plasma and urine using solid-phase extraction. J Chromatogr. 1987 Aug 7;419:233-42. [PubMed:3667781 ]
- Jitsufuchi N, Kudo K, Tokunaga H, Imamura T: Selective determination of sultopride in human plasma using high-performance liquid chromatography with ultraviolet detection and particle beam mass spectrometry. J Chromatogr B Biomed Sci Appl. 1997 Mar 7;690(1-2):153-9. [PubMed:9106039 ]
- Delarue C, Contesse V, Lefebvre H, Lenglet S, Grumolato L, Kuhn JM, Vaudry H: Pharmacological profile of serotonergic receptors in the adrenal gland. Endocr Res. 1998 Aug-Nov;24(3-4):687-94. [PubMed:9888560 ]
|
|---|